tumours
Theramex receives recommendation for YSELTY in Scotland
November 11, 2024Research and Development Pain, Reproductive health, appproval, tumours, women's health
Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …
First patient dosed in Cullinan Oncology’s phase 1 trial for CLN-617
December 15, 2023Research and Development Cullinan Oncology, Oncology, clinical trial, tumours
Cullinan Oncology has announced that the first patient has been dosed with CLN-617 in its phase 1 clinical trial, designed …
BioInvent and Transgene announce positive phase 1a solid tumour trial data
May 25, 2023Research and Development BioInvent, Oncology, Transgene, clinical trials, oncology, tumours
Sweden-based BioInvent and French Transgene, both biotech companies, have reported positive phase 1a data from a trial studying BT-001 for …
Breast cancer cells can be transformed into fat cells using combination therapy, study shows
January 16, 2019Research and Development Cancer, EMT, breast cancer, cells, oncology, tumours
An innovative cancer treatment can turn malignant breast cancer cells into fat cells, thus preventing the formation of metastases (the …
$350m collaboration deal for BMS and Five Prime Therapeutics
October 15, 2015Research and Development BMS, Bristol-Myers Squibb, R&D, five prime, immuno-oncology, tumours
Bristol-Myers Squibb has signed a collaboration agreement with the US biotech firm Five Prime Therapeutics, for a Colony Stimulating Factor …
AstraZeneca and Peregrine in immuno-oncology collaboration
August 24, 2015Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours
AstraZeneca and Peregrine Pharmaceuticals will collaborate on a clinical trial to test two of the companies’ cancer treatments. The Phase …
Sanofi, Evotec and Apeiron partner on immuno-oncology
August 10, 2015Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours
Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …
